A comparison of performance of the Ovsynch treatment program between cycling and non-cycling cows within seasonally-calving dairy herds.
OBJECTIVE
To compare performance of the Ovsynch program on reproductive performance between cycling and non cycling cows in seasonally-calving herds.


METHODS
An Ovsynch mating program (100 mg Gonadorelin on day 1 and day 9, 500 mg of Cloprostenol on day 7 with fixed time artificial insemination on day 10) was administered to 3,559 cows from 14 herds in Australia and New Zealand. Cycling status before planned start of mating was determined. All cows were treated and artificial insemination continued for at least 25 days after fixed time artificial insemination. Pregnancy testing was performed 75 to 100 days after fixed time artificial insemination. Multivariable modelling examined the impact of the Ovsynch program and other risk factors upon reproductive performance.


RESULTS
Thirty percent of cows were classified as no visible oestrous (NVO). Odds of being NVO increased significantly for cows that were young, recently calved, and in low body condition. The fixed time artificial insemination conception rate was 35.7% and 33.2%, 21-day pregnancy rate was 54.5% and 48.4% and 42-day pregnancy rate was 69.7% and 62.6% for cycling and NVO cows respectively. Odds of pregnancy increased significantly for cows calved more than 40 days by planned start of mating, in greater body condition, and cycling, and there was a significant interaction between body condition and cycling status in both models. The return-to-service rates by 24-days were 67.6% and 55.9% and by the end of the AI period were 86.9% and 81.5% for cycling and NVO cows respectively. Odds of return to service increased significantly for cows in greater condition score in both models. Odds of return were increased for cycling cows in the 24-day multivariable model.


CONCLUSIONS
The Ovsynch program may provide a useful treatment option for NVO cows within seasonally-calving pasture-based dairy herds.
Shephard
R W
RW
rshephard@gippslandhi.coop
D000818:Animals; D001315:Australia; D001823:Body Composition / Q000502:physiology; D001824:Body Constitution / Q000502:physiology; D002417:Cattle / Q000502:physiology*; D003008:Cloprostenol / Q000494:pharmacology; D004971:Estrus / Q000187:drug effects*; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000494:pharmacology; D007315:Insemination, Artificial / Q000662:veterinary; D008297:Male; D015999:Multivariate Analysis; D009520:New Zealand; D010062:Ovulation Induction / Q000379:methods / Q000662:veterinary*; D011247:Pregnancy; D018873:Pregnancy Rate; D012098:Reproduction / Q000187:drug effects* / Q000502:physiology; D012621:Seasons
D007987:Gonadotropin-Releasing Hormone; D003008:Cloprostenol